Services

Pharmacovigilance

Human Medicines

The development of the new pharmacovigilance legislation, which was the biggest change to the regulation of human medicines in the European Union (EU) since 1995, was based on the observation that adverse drug reactions (ADRs), ‘noxious and unintended’ responses to a medicine, caused around 197,000 deaths per year in the EU.

How to Reach us?

Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202

1000 Ljubljana

Slovenia

Our services:

  • Help in achieving compliance with the guidelines on Good Pharmacovigilance Practices (GVP)
  • Services of a QPPV (24/7) with access to medical adviser
  • Establishment and maintenance of the Pharmacovigilance system and
    Pharmacovigilance system master file (PSMF), including Quality System
  • Management of Critical pharmacovigilance processes and business continuity
  • Management and reporting of adverse reactions to medicinal products
  • Weekly monitoring of scientific literature
  • Ongoing benefit-risk evaluation
  • Preparation of Risk Management Plan and Risk minimisation measures
  • Medical writing (PSUR, RMP, etc.)
  • Signal detection and evaluation
  • Managing PASS, PAES
    Regulatory actions (safety variations, communications with stakeholders, etc.)
  • Electronic transmission of the pharmacovigilance data (Article 57),
    selection of appropriate tool and implementation of a quality system
  • Training of personnel
  • Setting up appropriate contractual arrangements and supervision
  • Audit and pre-inspection consultations

More ways,
we can help.

With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.

Don’t miss out

Follow us on LinkedIn

Watch our
promotional video

HOME

SERVICES

Regulatory Affairs

PharmacoVigilance

Medical Consultancy

Quality / GxP

Digital Consultancy

TEAM OF EXPERTS

ABOUT US

NEWS AND EVENTS

B2B PARTNER LOG-IN